Galea I, Bandyopadhyay S, Bulters D, Humar R, Hugelshofer M, Schaer D
Stroke. 2023; 54(7):1930-1942.
PMID: 37232189
PMC: 10289236.
DOI: 10.1161/STROKEAHA.123.040205.
Fauzi A, Thamrin A, Permana A, Ranuh I, Hidayati H, Hamdan M
J Clin Med. 2023; 12(7).
PMID: 37048818
PMC: 10094955.
DOI: 10.3390/jcm12072735.
Permana A, Bajamal A, Parenrengi M, Suroto N, Lestari P, Fauzi A
Surg Neurol Int. 2022; 13:206.
PMID: 35673677
PMC: 9168316.
DOI: 10.25259/SNI_1174_2021.
Pound P, Ram R
BMJ Open Sci. 2022; 4(1):e100041.
PMID: 35047687
PMC: 8749304.
DOI: 10.1136/bmjos-2019-100041.
Habibi-Koolaee M, Shahmoradi L, Niakan Kalhori S, Ghannadan H, Younesi E
Neurol Ther. 2021; 10(1):321-333.
PMID: 33886080
PMC: 8140017.
DOI: 10.1007/s40120-021-00248-1.
Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives.
Kuriakose D, Xiao Z
Int J Mol Sci. 2020; 21(20).
PMID: 33076218
PMC: 7589849.
DOI: 10.3390/ijms21207609.
Gasdermin Family: a Promising Therapeutic Target for Stroke.
Chen S, Mei S, Luo Y, Wu H, Zhang J, Zhu J
Transl Stroke Res. 2018; 9(6):555-563.
PMID: 30280366
DOI: 10.1007/s12975-018-0666-3.
Transplanting Mesenchymal Stem Cells for Treatment of Ischemic Stroke.
Wang F, Tang H, Zhu J, Zhang J
Cell Transplant. 2018; 27(12):1825-1834.
PMID: 30251564
PMC: 6300770.
DOI: 10.1177/0963689718795424.
Cerebral venous collaterals: A new fort for fighting ischemic stroke?.
Tong L, Guo Z, Ou Y, Yu Y, Zhang X, Tang J
Prog Neurobiol. 2017; 163-164:172-193.
PMID: 29199136
PMC: 6389333.
DOI: 10.1016/j.pneurobio.2017.11.001.
Effects of Female Sex Steroids Administration on Pathophysiologic Mechanisms in Traumatic Brain Injury.
Khaksari M, Soltani Z, Shahrokhi N
Transl Stroke Res. 2017; 9(4):393-416.
PMID: 29151229
DOI: 10.1007/s12975-017-0588-5.
Efficient and Fast Differentiation of Human Neural Stem Cells from Human Embryonic Stem Cells for Cell Therapy.
Han X, Yu L, Ren J, Wang M, Liu Z, Hu X
Stem Cells Int. 2017; 2017:9405204.
PMID: 29075299
PMC: 5624175.
DOI: 10.1155/2017/9405204.
Precision Stroke Animal Models: the Permanent MCAO Model Should Be the Primary Model, Not Transient MCAO.
McBride D, Zhang J
Transl Stroke Res. 2017; .
PMID: 28718030
PMC: 5772000.
DOI: 10.1007/s12975-017-0554-2.
Correcting the Trajectory of Stroke Therapeutic Research.
Pennypacker K, Bix G, Fraser J
Transl Stroke Res. 2017; 8(1):65-66.
PMID: 28039576
PMC: 5243812.
DOI: 10.1007/s12975-016-0517-z.